Hamdy Ahmed MD

Hamdy Ahmed MD is listed in filings as CMO at Curis, Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including 15 public disclosures. Recent filings connect the profile to Curis, Inc. (CRIS) and Vincerx Pharma, Inc. (VINC). The current snapshot covers public activity from Aug 14, 2024 to Mar 23, 2026. Reported amounts are shown as $50.0K to $798.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.